# Nice Investment Partners

> Nice Investment Partners is a VC fund backing Health Care. See 58 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Yongdungpo, South Korea
- Total investments: 58
- Last investment: Jun 2026
- Lead investor: 12%
- Last updated: Aug 2026
- Website: http://www.nicefni.co.kr

NICE Investment Partners is a new technology finance company whose main job is to increase corporate value by discovering and investing in new technology businesses with promising growth, providing various management support, business alliances, and strategic consulting to the invested companies.

## Contacts

5 contacts available for Nice Investment Partners. Shizune tracks 1 team members at Nice Investment Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/nice-investment-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1k–$1.9M |
| Series A | $2.1M–$26M |
| Series B | $3.7M–$16M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 16% |
| Information Technology | 7 | 12% |
| Software | 6 | 10% |
| E-Commerce | 5 | 9% |
| Biotechnology | 5 | 9% |

97 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 18 | 31% |
| Series B | 15 | 26% |
| Seed | 8 | 14% |
| Series C | 7 | 12% |
| Funding Round | 4 | 7% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 46 | 79% |
| Japan | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kim Yun won | auditor | 1 | https://shizune.co/investors/profile/kim-yun-won |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| FNCT Biotech | FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option. | $14M | Series B | Jun 16, 2026 |  |
| Motif Technologies | Motif Technologies is an AI deep tech company that develops proprietary AI models and provides optimized cloud infrastructure for AI deployment, from everyday personal use to enterprise-scale applications. | $16M | Series B | May 27, 2026 |  |
| Pensées | Pensées is a 3D bio-printer company that develops cultured meat through 3D bioprinting technology. | $4.5M | Series A | Dec 29, 2025 |  |
| Biocom | Biocom is a green bio management company. | $2.6M | Series A | Dec 29, 2025 |  |
| Quantum AI | Quantum AI is an AI data company that offers offline and online data collection and analysis services. Currently, Quantum AI is providing various services centered on the financial sector, including AI document processing automation, intelligent voice consultation, assetization of unstructured financial data based on its own language model, and AIsearch. Utilizing a proprietary AI recognition engine, the company has integrated and analyzed various data sources, including financial documents, customer consultation history, and market news, and have carried out numerous AI data assetization projects for major domestic commercial banks and insurance companies. | $5M | Series B | Nov 06, 2025 |  |
| Gadget Korea | Gadget korea offers data roaming services. | $7.7M | Series A | Oct 27, 2025 |  |
| Lutem Bio | Lutem Bio is an online medicine firm that is intended for general health. The company provides medicine for memory, cognition, immunity, gut, joints, and bones, among others, enabling customers to get medicines recommended by a doctor. | $3M | Series A | Oct 17, 2025 |  |
| Plastal | Plastal is a mechanical and chemical engineering company that offers polymer, metal, and mold injection services. The company specializes in using its core technology required for bonding between metal and plastic resin, mold technology, injection conditions, and milling capabilities, enabling manufacturing companies to avail themselves of theproducts they desire. | $13.1M | Series B | Oct 16, 2025 |  |
| Doctorblet Healthcare | dr.blet and wellness brand that bridges the gap between clinical expertise and daily nutrition. The company distinguishes itself by emphasizing "doctor-developed" formulas, aiming to provide science-backed supplements that are both effective and safe for long-term consumption. | $39.1M | Series A | Jul 02, 2025 |  |
| Vibeon | Vibeon is a data company that provides artificial intelligence services for education. | $2.1M | Series A | Apr 10, 2025 |  |

10 of 58 investments shown.

## Co-investors
- [Korea Development Bank](https://shizune.co/investors/profile/korean-development-bank) — VC Fund, 8 deals together
- [IBK Capital](https://shizune.co/investors/profile/ibk-capital-951b) — VC Fund, 5 deals together
- [Kolon Investment](https://shizune.co/investors/profile/kolon-investment) — VC Fund, 5 deals together
- [NH Bank](https://shizune.co/investors/profile/nh-bank) — VC Fund, 5 deals together
- [HB Investment](https://shizune.co/investors/profile/hb-investment) — VC Fund, 4 deals together
- [KT Investment](https://shizune.co/investors/profile/kt-investment-inc) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)
- [Climate VC Funds in South Korea](https://shizune.co/investors/climate-vc-funds-south-korea)
- [Climate Investors in South Korea](https://shizune.co/investors/climate-investors-south-korea)
- [Manufacturing Investors in South Korea](https://shizune.co/investors/manufacturing-investors-south-korea)
- [Manufacturing VC Funds in South Korea](https://shizune.co/investors/manufacturing-vc-funds-south-korea)

## FAQ

### What does Nice Investment Partners invest in?

Nice Investment Partners invests primarily in Health Care, Information Technology and Software startups, most often at Series A and Series B stage. Most of the 58 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Nice Investment Partners's check size?

Nice Investment Partners typically joins rounds of $1k–$1.9M at Seed, $2.1M–$26M at Series A and $3.7M–$16M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Nice Investment Partners participates in.

### How do I contact Nice Investment Partners?

Public channels for Nice Investment Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Nice Investment Partners?

The team at Nice Investment Partners includes Kim Yun won (auditor). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co